Using behavioral patterns across species in mood disorder research

Neuromethods

Volumn 63, Issue , 2011, Pages 21-41

  Young, Jared W ^a   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Behavioral pattern monitor; Bipolar disorder; Cross species assessment; Exploration patterns; Locomotion; Mania; Motor activity; Mouse

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BETA ADRENERGIC RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; METHAMPHETAMINE; NICOTINIC RECEPTOR ALPHA4BETA2; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; VALPROIC ACID;

ANIMAL BEHAVIOR; ARTICLE; BEHAVIOR; BIPOLAR DISORDER; BIPOLAR MANIA; DRUG DEPENDENCE; DRUG EFFECT; ENTROPY; EXPLORATORY BEHAVIOR; HUMAN; HYPERACTIVITY; LOCOMOTION; MOOD DISORDER; MOTOR ACTIVITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REARING; SCHIZOPHRENIA; STEREOTYPY;

ANIMALIA; RODENTIA;

EID: 80054765889     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-61779-313-4_2     Document Type: Article

References (83)

1. Paulus M, Geyer MA (1996): Assessing the organization of motor behavior: New applroaches based on the behavior of complex physical systems. In: Ossenkopp KP, Kavaliers M, Sanberg PR, editors. Measuring movement and locomotion: From invertebrate animals to humans. New York: Chapman & Hall.
2. Drai D, Golani I (2001): SEE: a tool for the visualization and analysis of rodent exploratory behavior. Neuroscience and biobehavioral reviews. 25:409-426. (Pubitemid 32879298)
3. Eilam D, Shefer G (1997): The developmental order of bipedal locomotion in te jerboa (Jaculus orientalis): pivoting, creeping, quadrupedalism, and bipedalism. Developmental psychobiology. 31:137-142. (Pubitemid 127465929)
4. Ossenkopp K, Kavaliers M, Sanberg PR (1996): Measuring Moevement and Locomotion: From Invertebrates to Humans. New York: Chapman & Hall.
5. Robbins TW (1977): A critique of methods available for the measurement of spontaneous locomotor activity. In: Iversen LL, Iversen SD, editors. Handbook of Psychopharmacology. New York, Plenum Press, 7:37-82.
6. Gould TD, Dao DT, Kovacsics CE (2009): The open field test. In: Gould TD, editor. Mood and anxiety related phenotypes in mice: Characterization using behavioral tests. New York: Humana Press, pp 1-20.
7. File SE, Wardill AG (1975): The reliability of the hole-board apparatus. Psychopharmacologia. 44:47-51.
8. Geyer MA (1990): Approaches to the characterization of drug effects on locomotor activity in rodents. In: Adler MW, Cowan A, editors. Testing and Evaluation of Drugs of Abuse. New York: Wiley-Liss, Inc.
9. Geyer MA, Paulus M (1996): Multivariate Analyses of Locomotor and Investigatory Behavior in Rodents. In: Ossenkopp K, Kavaliers M, Sanberg PR, editors. Mearusing Movement and Locomotion: From Invertebrates to Humans. New York: Chapman & Hall.
10. Paulus M, Geyer MA (1996): Assessing the Organization of Motor behavior: New Approaches Based on the Behavior of Complex Physical Systems. In: Ossenkopp K, Kavaliers M, Sanberg PR, editors. Measuring Movement and Locomotion: From Invertebrates to Humans. New York: Chapman & Hall.
11. Geyer MA, Russo PV, Masten VL (1986): Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacology, biochemistry, and behavior. 25: 277-288. (Pubitemid 16040937)
12. Paulus MP, Geyer MA (1993): Three independent factors characterize spontaneous rat motor activity. Behav Brain Res. 53:11-20. (Pubitemid 23074026)
13. Eilam D, Golani I (1988): The ontogeny of exploratory behavior in the house rat (Rattus rattus): the mobility gradient. Developmental psychobiology. 21:679-710. (Pubitemid 18260935)
14. Kafkafi N, Lipkind D, Benjamini Y, Mayo CL, Elmer GI, Golani I (2003): SEE locomotor behavior test discriminates C57BL/6 J and DBA/2 J mouse inbred strains across laboratories and protocol conditions. Behavioral neuroscience. 117:464-477. (Pubitemid 36686964)
15. Krebs-Thomson K, Geyer MA (1998): Evidence for a functional interaction between 5-HT1A and 5-HT2 receptors in rats. Psychopharmacology. 140:69-74. (Pubitemid 28524309)
16. Gold LH, Koob GF, Geyer MA (1988): Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. The Journal of pharmacology and experimental therapeutics. 247:547-555.
17. Paulus MP, Geyer MA (1991): A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology. 104:6-16.
18. Paulus M, Geyer MA, Mandell AJ (1991): Statistical mechanics of a neurobiological dynamical system: The spectrum of local entropies (S(a)) applied to cocaine-perturbed behavior Physica A. 174:567-577.
19. Paulus MP, Geyer MA, Gold LH, Mandell AJ (1990): Application of entropy measures derived from the ergodic theory of dynamical systems to rat locomotor behavior. Proceedings of the National Academy of Sciences of the United States of America. 87:723-727.
20. Lehmann-Masten VD, Geyer MA (1991): Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats. Neuropharmacology. 30:629-636.
21. Paulus MP, Geyer MA (1991): A scaling approach to find order parameters quantifying the effects of dopaminergic agents on unconditioned motor activity in rats. Progress in neuropsychopharmacology & biological psychiatry. 15:903-919.
22. Adams LM, Geyer MA (1982): LSD-induced alterations of locomotor patterns and exploration in rats. Psychopharmacology. 77:179-185. (Pubitemid 12038119)
23. Flicker C, Geyer MA (1982): Behavior during hippocampal microinfusions. IV. Transmitter interactions. Brain research. 257:137-147. (Pubitemid 12178964)
24. Bushnell PJ (1987): Effects of scopolamine on locomotor activity and metabolic rate in mice. Pharmacology, biochemistry, and behavior. 26: 195-198. (Pubitemid 18009452)
25. Collins C, Laird RI, Richards PT, Starmer GA, Weyrauch S (1979): Aspirin-caffeine interaction in the rat. The Journal of pharmacy and pharmacology. 31:611-614. (Pubitemid 9257301)
26. Fink JS, Smith GP (1979): Abnormal pattern of amphetamine locomotion after 6-OHDA lesion of anteromedial caudate. Pharmacology, biochemistry, and behavior. 11:23-30. (Pubitemid 10161346)
27. Fitzgerald RE, Berres M, Schaeppi U (1988): Validation of a photobeam system for assessment of motor activity in rats. Toxicology. 49:433-439.
28. Gould TJ, Keith RA, Bhat RV (2001): Differential sensitivity to lithium's reversal of amphetamine-induced open-field activity in two inbred strains of mice. Behavioural brain research. 118:95-105. (Pubitemid 32037118)
29. Kulkarni SK, Dandiya PC (1975): Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats. Pharmakopsychiatrie, Neuro-Psychopharmakologie. 8:45-50.
30. Meliska CJ, Loke WH (1984): Caffeine and nicotine: differential effects on ambulation, rearing and wheelrunning. Pharmacology, biochemistry, and behavior. 21:871-875. (Pubitemid 15150738)
31. Paulus MP, Geyer MA (1992): The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity. Neuropsychopharmacology. 7:15-31.
32. Sessions GR, Meyerhoff JL, Kant GJ, Koob GF (1980): Effects of lesions of the ventral medial tegmentum on locomotor activity, biogenic amines and responses to amphetamine in rats. Pharmacology, biochemistry, and behavior. 12:603-608. (Pubitemid 10070130)
33. Rao VS, Santos FA, Paula WG, Silva RM, Campos AR (1999): Effects of acute and repeated dose administration of caffeine and pentoxifylline on diazepam-induced mouse behavior in the holeboard test. Psychopharmacology. 144:61-66. (Pubitemid 29242671)
34. Marco EM, Llorente R, Perez-Alvarez L, Moreno E, Guaza C, Viveros MP (2005): The kappa-opioid receptor is involved in thestimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety. Behavioural brain research. 163:212-218. (Pubitemid 41138055)
35. Marks MJ, Stitzel JA, Romm E, Wehner JM, Collins AC (1986): Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. Molecular pharmacology. 30:427-436. (Pubitemid 17202420)
36. Makanjuola RO, Hill G, Dow RC, Campbell G, Ashcroft GW (1977): The effects of psychotropic drugs on exploratory and stereotyped behaviour of rats studied on a hole-board. Psychopharmacology. 55:67-74. (Pubitemid 8223204)
37. Antoniou K, Kafetzopoulos E (1991): A comparative study of the behavioral effects of d-amphetamine and apomorphine in the rat. Pharmacology, biochemistry, and behavior. 39:61-70.
38. Gordon D, Beck CH (1984): Subacute apomorphine injections in rats: effects on components of behavioral stereotypy. Behavioral and neural biology. 41:200-208. (Pubitemid 14043204)
39. Rebec GV, Bashore TR (1984): Critical issues in assessing the behavioral effects of amphetamine. Neuroscience and biobehavioral reviews. 8:153-159. (Pubitemid 14118787)
40. Geyer MA, Russo PV, Segal DS, Kuczenski R (1987): Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats. Pharmacology, biochemistry, and behavior. 28:393-399. (Pubitemid 18002792)
41. Paulus MP, Geyer MA (1993): Quantitative assessment of the microstructure of rat behavior: I, f(d), the extension of the scaling hypothesis. Psychopharmacology. 113:177-186. (Pubitemid 24001990)
42. Geyer MA, Gordon J, Adams LM (1985): Behavioral effects of xylamine-induced depletions of brain norepinephrine: interaction with LSD. Pharmacology, biochemistry, and behavior. 23:619-625. (Pubitemid 16191758)
43. Flicker C, Geyer MA (1982): Behavior during hippocampal microinfusions. I. Norepinephrine and diversive exploration. Brain research. 257:79-103. (Pubitemid 12129854)
44. Segal DS, Geyer MA (1976): Pre- and postjunctional supersensitivity: differentiation by intraventricular infusions of norepinephrine and methoxamine. Psychopharmacology. 50:145-148.
45. Geyer MA, Masten VL (1989): Increases in diversive exploration in rats during hippocampal microinfusions of isoproterenol but not methoxamine. Physiology & behavior. 45:213-217. (Pubitemid 19077463)
46. Baumann B, Danos P, Krell D, Diekmann S, Leschinger A, Stauch R, et al. (1999): Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. The Journal of neuropsychiatry and clinical neurosciences. 11:71-78. (Pubitemid 29070667)
47. Manji HK, Potter W (1997): Monoaminergic Systems in Bipolar Disorder. In: Young LT, Joffe RT, editors. Bipolar Disorder: Biological Models and their Clinical Applications. New York: Dekker.
48. Manji HK, Quiroz JA, Payne JL, Singh J, Lopes BP, Viegas JS, et al. (2003): The underlying neurobiology of bipolar disorder. World Psychiatry. 2:136-146.
49. Vawter MP, Freed WJ, Kleinman JE (2000): Neuropathology of bipolar disorder. Biological psychiatry. 48:486-504.
50. Young LT, Warsh JJ, Kish SJ, Shannak K, Hornykeiwicz O (1994): Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biological psychiatry. 35:121-127. (Pubitemid 24084128)
51. Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, et al. (2009): A reversetranslational study of dysfunctional exploration in psychiatric disorders: from mice to men. Archives of general psychiatry. 66:1072-1080.
52. Carey RJ (1982): Unilateral 6-hydroxydopamine lesions of dopamine neurons produce bilateral self-stimulation deficits. Behavioural brain research. 6:101-114. (Pubitemid 12032950)
53. Morita T, Sonoda R, Nakato K, Koshiya K, Wanibuchi F, Yamaguchi T (2000): Phencyclidine-induced abnormal behaviors in rats as measured by the hole board apparatus. Psychopharmacology. 148:281-288. (Pubitemid 30136735)
54. Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA (2010): The manialike exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Pharmacology Biochemistry and Behavior. 96:7-15.
55. Gresack J, Powell S, Geyer M, Poore MS, Coste S, Risbrough V (2010): CRF2 null mutation increases sensitivity to isolation rearing effects on locomotor activity in mice. Neuropeptides. 44:349-353.
56. Risbrough VB, Masten VL, Caldwell S, Paulus MP, Low MJ, Geyer MA (2006): Differential contributions of dopamine D(1), D(2), and D(3) receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology. 31:2349-2358. (Pubitemid 44607051)
57. Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, et al. (2009): 5-HT(2A) and 5-HT(2 C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology. 34:1958-1967.
58. Halberstadt AL, Lehmann-Masten VD, Geyer MA, Powell SB (2011): Interactive effects ofmGlu5 and 5-HT(2A) receptors on locomotor activity in mice. Psychopharmacology. 215(1):81-92.
59. Young JW, Minassian A, Paulus MP, Geyer MA, Perry W (2007): A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neuroscience and biobehavioral reviews. 31:882-896. (Pubitemid 47285352)
60. Henry BL, Minassian A, Young JW, Paulus MP, Geyer MA, Perry W (2010): Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neuroscience and biobehavioral reviews. 34:1296-1306.
61. Halberstadt AL, Koedood L, Powell SB, Geyer MA (2010): Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. Journal of psychopharmacology (Oxford, England).
62. Ralph-Williams RJ, Paulus MP, Zhuang X, Hen R, Geyer MA (2003): Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biological psychiatry. 53:352-359. (Pubitemid 36173965)
63. Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA (2010): GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology. 208:443-454.
64. Amsterdam JD, Newberg AB (2007): A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology. 55:167-170. (Pubitemid 47525236)
65. Horschitz S, Hummerich R, Lau T, Rietschel M, Schloss P (2005): A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression. Molecular psychiatry. 10: 1104-1109. (Pubitemid 43251100)
66. Teicher MH (1995): Actigraphy and motion analysis: new tools for psychiatry. Harvard Review of Psychiatry. 3:18-35.
67. Teicher MH, Lawrence JM, Barber NI, Finklestein SP, Lieberman H, Baldessarini RJ (1986): Altered locomotor activity in neuropsychiatric patients. Progress in Neuropsychopharmacology and Biological Psychiatry. 10: 755-761. (Pubitemid 17185929)
68. Wolff EA, Putnam FW, Post RM (1985): Motor activity and affective illness. Arch Gen Psychiatry. 42:288-294.
69. Pierce K, Courchesne E (2001): Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biological psychiatry. 49:655-664. (Pubitemid 32328116)
70. Minassian A, Henry BL, Geyer MA, Paulus MP, Young JW, Perry W (2009): The quantitative assessment of motor activity in mania and schizophrenia. Journal of affective disorders. 120:200-206.
71. Perry W, Minassian A, Henry B, Kincaid M, Young JW, Geyer MA (2010): Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry research. 178:84-91.
72. Henry BL, Minassian A, van Rhenen M, Young JW, Geyer MA, Perry W (2011): Effect of methamphetamine dependence on inhibitory deficits in a novel human open field paradigm. Psychopharmacology. 215(4):697-707.
73. Pini S, de Queiroz V, Dell'Osso L, Abelli M, Mastrocinque C, Saettoni M, et al. (2004): Cross-sectional similarities and differences between schizophrenia, schizoaffective disorder and mania or mixed mania with mood-incongruent psychotic features. Eur Psychiatry. 19:8-14. (Pubitemid 38210423)
74. Lhermitte F (1983): 'Utilization behaviour' and its relation to lesions of the frontal lobes. Brain. 106 (Pt 2):237-255. (Pubitemid 13098510)
75. Goto Y, Yang CR, Otani S (2010): Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biological psychiatry. 67:199-207.
76. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM (2009): Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry. 195:194-201.
77. Koenigs M, Grafman J (2009): The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res. 201:239-243.
78. Bechara A, Damasio AR, Damasio H, Anderson SW (1994): Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 50:7-15.
79. Young JW, van Enkhuizen JE, Winstanley CA, Geyer MA (in press): Increased gambling behaviour in a mouse model of mania. Journal of Psychopharmacology.
80. Vivometrics (2002): The LifeShirt SystemTM. Ventura, CA.
81. Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W (2010): Heart rate variability in bipolar mania and schizophrenia. Journal of psychiatric research. 44(3):168.
82. Eilam D (2003): Open-field behavior withstands drastic changes in arena size. Behav Brain Res. 142:53-62. (Pubitemid 36677590)
83. Paulus MP, Geyer MA (1997): Environment and uncoditioned motor behavior influences of drugs and environmental geometry on behavioral organization in rats. Psychobiology. 25:324-337.